Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2013
01/22/2013US8357503 Hydrolases, nucleic acids encoding them and methods for making and using them
01/22/2013US8357499 Expression of functional human olfactory cyclic nucleotide gated (CNG) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators
01/22/2013US8357493 Method for detecting mycobacteria using deleted sequences in M. bovis BCG/M. bovis or tuberculosis
01/22/2013US8357372 Agent for treating allergic or hypersensitivity condition
01/22/2013US8357370 Anti-D monoclonal antibodies
01/22/2013US8357363 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom
01/22/2013CA2720634C Nuclear conditional male sterility system in brassica napus and its use for producing male fertile hybrid seed of brassica napus
01/22/2013CA2692552C Novel protein isolated from pleurotus cornucopiae
01/22/2013CA2653939C Immunostimulatory oligonucleotides and use thereof in pharmaceuticals
01/22/2013CA2650026C Pre-b cell proliferation and lymphoblastic leukemia/high-grade lymphoma in mir155 transgenic mice
01/22/2013CA2622074C Rapid production of high titer virus
01/22/2013CA2611452C Method of manufacturing probe-immobilized carrier
01/22/2013CA2589657C Production of .beta.-glucosidase, hemicellulase and ligninase in e1 and flc-cellulase-transgenic plants
01/22/2013CA2588965C Novel chimeric plasminogen activators and their pharmaceutical use
01/22/2013CA2580761C Isopentenyl transferase sequences and methods of use
01/22/2013CA2529243C A method of selectively producing male or female sterile plants
01/22/2013CA2522597C Mouse deficient in glutamate transporter glast function
01/22/2013CA2509337C Process for purification of plasmid dna
01/22/2013CA2506798C Compositions and systems for the regulation of genes
01/22/2013CA2483819C Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
01/22/2013CA2477519C Method of error reduction in nucleic acid populations
01/22/2013CA2474939C Methods for modifying plant responses to stress and correspondingly derived plants
01/22/2013CA2452582C G-csf conjugates
01/22/2013CA2448607C Colloidal metal compositions and methods
01/22/2013CA2443145C Uncoupled productive and catabolic host cell pathways
01/22/2013CA2441663C Viral vectors and their use in therapeutic methods
01/22/2013CA2429031C Regulation of flavonoid expression in alfalfa using maize regulatory genes
01/22/2013CA2425862C Cd19-specific redirected immune cells
01/22/2013CA2375619C Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
01/22/2013CA2346122C Stabilized bioactive peptides and methods of identification, synthesis and use
01/22/2013CA2343716C Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions
01/22/2013CA2329267C A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upflp, eucaryotic release factor 1 and eucaryotic release factor 3
01/17/2013WO2013010135A1 Sumoylation of serca2a and cardiovascular disease
01/17/2013WO2013010133A2 Corn products and methods for their production
01/17/2013WO2013010124A1 Lignification reduction in plants
01/17/2013WO2013010101A1 Method of treating and reducing the risk of acute myelogenous leukemia
01/17/2013WO2013010074A1 Multimodal methods for simultaneous detection and quantification of multiple nucleic acids in a sample
01/17/2013WO2013010064A1 Crop resistance to nematodes
01/17/2013WO2013010062A2 Nucleic acid complexity reduction
01/17/2013WO2013010057A1 Compositons and methods for the production of isoprene
01/17/2013WO2013009967A2 Identifying affinity-matured human antibodies
01/17/2013WO2013009868A1 Compositions and methods for making selenocysteine containing polypeptides
01/17/2013WO2013009809A2 A method of determining the prognosis of hepatocellular carcinomas using a multigene signature associated with metastasis
01/17/2013WO2013009717A1 Virion derived protein nanoparticles for delivering diagnostic or therapeutic agents for the treatment of skin-related diseases
01/17/2013WO2013009679A2 Over-expression of a putative oxidoreductase (ucpa) for increasing furfural or 5-hydroxymethylfurfural tolerance
01/17/2013WO2013009632A2 Methods of detecting hereditary cancer predisposition
01/17/2013WO2013009525A1 Method for increasing the efficiency of double-strand break-induced mutagenssis
01/17/2013WO2013009340A1 Methods and compositions for chlamydia trachomatis diagnostic testing
01/17/2013WO2013009143A2 Marker for diagnosing diabetic retinopathy
01/17/2013WO2013009103A2 Recombinant microorganism which secretes egf via an abc transporter, and composition for alleviating or treating peptic ulcers comprising same as an active ingredient
01/17/2013WO2013009084A2 Composition for simultaneously detecting mycobacterium tuberculosis and nontuberculous mycobacteria by means of real-time multiplex polymerase chain reaction comprising nested hybridization pna probe system having parallel binding structure, and method for detection using same
01/17/2013WO2013009070A2 Nested hybridization pna probe system having parallel binding structure
01/17/2013WO2013009018A1 Novel esterase derived from compost metagenome, and production method therefor
01/17/2013WO2013008911A1 Method and kit for predicting prognosis of primary central nervous system lymphoma patient, and use
01/17/2013WO2013008898A1 Novel dna polymerase
01/17/2013WO2013008881A1 Ischemic disease therapeutic agent
01/17/2013WO2013008877A1 Novel dna polymerases
01/17/2013WO2013008709A1 Method and kit for diagnosing glaucoma in dogs
01/17/2013WO2013008480A1 Mutant β-glucosidase, enzyme composition for decomposing biomass, and method for producing sugar solution
01/17/2013WO2013007874A1 A transgenic animal comprising a deletion or functional deletion of the 3'utr of an endogenous gene.
01/17/2013WO2013007848A2 Method for increasing or decreasing the development of sylleptic or proleptic branching in a ligneous plant
01/17/2013WO2013007821A1 Screening method
01/17/2013WO2013007820A1 Screening method
01/17/2013WO2013007728A1 Method for improving the resistance of plants to viruses
01/17/2013WO2013007703A1 CLASS A CpG OLIGONUCLEOTIDES FOR PREVENTION OF VIRAL INFECTION IN CATS
01/17/2013WO2013007656A1 A transgenic system for reversibly immortalizing mammalian quiescent cells
01/17/2013WO2013007388A1 Bacterial host strain expressing recombinant dsbc
01/17/2013WO2013007099A1 Method for large-scale synthesis of long-chain nucleic acid molecule
01/17/2013WO2013006956A1 Methods and uses of a modified cecropin for treating endoparasitic and bacterial infections
01/17/2013WO2013006953A1 Genes and proteins for alkanoyl-coa synthesis
01/17/2013WO2012162422A3 Transgenic chicken comprising an inactivated immunoglobulin gene
01/17/2013WO2012162243A3 Anti-cgrp compositions and use thereof
01/17/2013WO2012161956A3 High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
01/17/2013WO2012161539A3 Sirna for inhibiting the expression of bhrf1 and composition comprising same
01/17/2013WO2012158639A3 Recombinant fusion proteins and methods for use thereof for treatment or prevention of papillomavirus infection
01/17/2013WO2012157945A3 Method for expressing a target protein at the surface of a vacuole, and drug delivery carrier
01/17/2013WO2012156839A3 Splice - less lentiviral vectors for safter gene therapy applications
01/17/2013WO2012151263A3 A synthetic hepatitis c genome and methods of making and use
01/17/2013WO2012150973A9 Compositions for regulating iron homeostasis and methods of using same
01/17/2013WO2012149245A3 Genomic signatures of metastasis in prostate cancer
01/17/2013WO2012149162A3 Green process for producing polyhydroxyalkanoates and chemicals using a renewable feedstock
01/17/2013WO2012148820A3 Method for controlling weeds in a field of cotton plants
01/17/2013WO2012145582A3 Methods and compositions for the specific inhibitions of egfr by double-stranded rna
01/17/2013WO2012144799A3 Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides
01/17/2013WO2012143382A3 Gpr177 as target and marker in tumors
01/17/2013WO2012135848A3 Melatonin-based treatment and diagnosis of bile duct disease
01/17/2013WO2012106026A3 Efficient sterilization of fish by disruption of germ cell development
01/17/2013WO2012087966A3 Targeted perhydrolases
01/17/2013WO2012080968A3 Isolation of plasmid dna in aqueous two-phase systems using neutral polymers derivatized with cationic groups
01/17/2013WO2012071580A3 Enhanced gene expression
01/17/2013WO2012068445A3 Modification of sucrose distribution in plants
01/17/2013WO2011152694A8 Fusion protein having factor vii activity
01/17/2013US20130019347 Plants having enhanced yield-related traits and a method for making the same
01/17/2013US20130019346 Plants having enhanced yield-related traits and method for making the same
01/17/2013US20130019345 Florigen-activating complex
01/17/2013US20130019344 Rubisco Activase with Increased Thermostability and Methods of Use Thereof
01/17/2013US20130019343 Expression Cassettes for Seed-Preferential Expression in Plants
01/17/2013US20130019342 Polynucleotides encoding trehalose-6-phosphate phosphatase and methods of use thereof
01/17/2013US20130019341 Desaturases of a green microalga and uses thereof
01/17/2013US20130019340 Plant resistant to environmental stress and method for producing the same